Helen Susan Kim, Director, 10% Owner at Aktis Oncology, Inc. (AKTS), bought 5,694,370 shares at $18.00 ($15.0M) on 2026-01-12, disclosed to the SEC on 2026-01-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,859,370 | $0 | 0.0% |
| 2 | $18.00 | 22,545 | $406K | 2.7% |
| 3 | $18.00 | 812,455 | $14.6M | 97.3% |
| Total | $2.64 avg | 5,694,370 | $15.0M | 100% |
| Filing → |
| AMTI | SELL | 2021-07-06 | $17.3M | — | Filing → |
| KITE | SELL | 2017-09-27 | $1.1M | — | Filing → |
| KITE | SELL | 2017-08-14 | $1.5M | — | Filing → |